Back to search

Aristotle University Of Thessaloniki (AUTH)

Πρώιμοι δείκτες ενδοθηλιοπάθειας σε γυναίκες με το σύνδρομο των πολυκυστικών ωοθηκών

Abstract

dc:description

Polycystic ovary syndrome (PCOS) is probably the most frequent endocrinopathy in women of reproductive age. Its pathogenesis consists of hypothalamic-pituitary disturbances, disturbed gonadal stereoidogenesis and hyperandrogenism, and resistance to insulin, presented with higher occurrence in women with the syndrome independently of obesity. The concomitant presence and interaction of hyperandrogenemia and insulin resistance are associated with increased metabolic and cardiovascular morbidity, mostly expressed as dyslipidaemia, glucose intolerance (~35%), diabetes mellitus type 2 (~10%), coagulability disturbances and hypertension. All of the above disorders are essentially linked to endothelial malfunction, which leads to subclinical atherosclerosis and chronic low-grade vascular inflammation. While scientific literature addressing the levels of early markers of endothelial malfunction Endothelin-1 (ET-1) and soluble E-selectin (sESel) in women with the polycystic ovary syndrome (PCOS) is very rare, works investigating the levels of asymmetrical dimethyl-arginine (ADMA) are simply nonexistant. Therefore, the present study was designed with the following aims: a) compare the basal levels of three well-known markers of endothelial dysfunction, namely ET-1, sESel and ADMA, between women with polycystic ovary syndrome (PCOS) and healthy controls, b) assess the possible correlation between the concentrations of ET-1, sESel and ADMA and their relationship to the hormonal and metabolic parameters of the syndrome and c) determine and compare the effects of treatment with natural or synthetic estrogens, combined with anti-androgens, on the hormonal and metabolic features of PCOS and on the levels of ET-1, sESel and ADMA. One hundred six women diagnosed with PCOS and 30 healthy controls were involved in the study. Blood withdrawal took place during the early productive phase, between the 3rd and the 7th day of the menstrual cycle, in the group of the healthy donors, while patients gave blood between the 3rd and the 7th day after a hemorrhagic episode. In all blood samples the levels of FSH, LH, PRL, testosterone, Δ₄-androstenedione, DHEA-S, 17a-OH-progesterone, SHBG, insulin, glucose, ET-1, sESel and ADMA were measured, and the levels of the Free Androgen Index (FAI), the markers of Insulin resistance (HOMA-IR) and the ratio of glucose over insulin (G/I) before fasting, were determined. Moreover, a morphological assessment of the ovaries of all participants was performed the same day by intercervical sonography. Women with PCOS were randomly assigned to one of the following 5 therapeutic protocols: Νatural estrogens a. 17β-estradiol + cyproterone acetate 50 mg (n=21) b. Conjugated estrogen+ cyproterone acetate 50 mg (n=21) Synthetic estrogens c. Ethinyl estradiole + cyproterone acetate 2 mg (n=21) d. Ethinyl estradiole + cyproterone acetate 52 mg (n=22) e. Ethinyl estradiole + desogestrel (n=21). In women with PCOS, levels of T, SHBG, ET-1, sESel and ADMA were measured again after 3, 6 and 12 months of treatment, and the concentrations of insulin and glucose after 12 months of treatment. The results of these measurements revealed that baseline concentrations of ET1 and ADMA were significantly higher in women with PCOS than in healthy controls (p=0.009 and 0.038 respectively) and they positively correlated with each other (r=0.285, P=0.001). Concomitant treatments with synthetic estrogens and antiandrogens resulted in a significant decrease in the levels of Testosterone (T), (F=29.42, P<0.001), with no specific difference between the various protocols, and in a pronounced increase of SHBG levels (F=51.59, P<0.001), leading to an even more pronounced decrease of free androgen index (FAI) values (F=1.99, P=0.036). These results are indicative of a higher effectiveness of the treatment with synthetic estrogens over natural products. ADMA levels decreased significantly following treatment, to levels comparable to the controls (P<0.001), regardless of the scheme used, whereas a small but statistically significant decrease in Insulin Resistance occurred in all schemes used. The present data suggest that women with PCOS develop endothelial malfunction, the latter being ameliorated by administration of natural or synthetic estrogens and anti-androgens. Such an improvement seems to be independent of IR, which is often considered as a hallmark of PCOS pathogenesis.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Charitidou, C.
  • Χαριτίδου, Χριστίνα

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19351

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Charitidou, C.; Χαριτίδου, Χριστίνα. Πρώιμοι δείκτες ενδοθηλιοπάθειας σε γυναίκες με το σύνδρομο των πολυκυστικών ωοθηκών. Aristotle University Of Thessaloniki (AUTH), 2008. http://hdl.handle.net/10442/hedi/19351